Cannabis Report
Home > Boards > US OTC > Biotechs >

Anthera Pharmaceuticals, Inc. (ANTH)

ANTH RSS Feed
Add ANTH Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor
Search This Board: 
Last Post: 7/8/2018 11:58:37 PM - Followers: 71 - Board type: Free - Posts Today: 0


 


 Anthera Pharmaceuticals Inc.     


                                              Nasdaq: ANTH


 

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company has two product candidates in development.

 

Sollpura is Anthera’s novel biotechnology-derived pancreatic enzyme replacement therapy for the potential treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

Blisibimod is Anthera’s BAFF inhibitor for the potential treatment of systemic lupus erythematosus and IgA nephropathy.


Pipeline



                            Contact Info                                                                           
                                                                           

Anthera Pharmaceuticals, Inc. 

25801 Industrial Blvd, Suite B • Hayward, CA 94545



Press Contact: pr@anthera.com


Business Development: bd@anthera.com


 Vendors: ap@anthera.com


 Website: www.anthera.com

 

------>>Latest Developments<<-----

December 06, 2016

J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...

1
 
         
___________________________________________________________________________________________________________________________________________
Outstanding Share Data
October 31 ,2016,the Company had 41,955,126 common shares issued and outstanding
July 31,2016 the Company had 41,427,352 common shares issued and outstanding
April 27,2016 the Company had 40,987,145 common shares issued and outstanding
February 29,2016 the Company had 40,004,037 common shares issued and outstanding
November 1,2015 the Company had 39,875,405 common shares issued and outstanding
August 1,2015 the Company had 39,703,998 common shares issued and outstanding
May 1,2015 the Company had 35,816,364 common shares issued and outstanding
February 28,2015 the Company had 29,091,773 common shares issued and outstanding
November 10,2014 the Company had 22,939,553 common shares issued and outstanding
____________________________________________________________________________________________________________________________________________

MAJOR HOLDERS

 

68% of the outstanding owned by these longs

Outstanding 42mil minus Major ownership of 28.5mil = 13.5mil free trading float


28.5mil Major Holders in this,15mil Institutions,7.5mil Direct Holders,6mil Mutual Funds= 68% of 42mil os 


http://www.barrons.com/quote/stock/us/xnas/anth?mod=DNH_S

________________________________________________________________


http://finance.yahoo.com/q?s=ANTH

   Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation,

including cardiovascular and autoimmune diseases. We currently have a Phase 2 clinical program, blisibimod.It was just recently approved by FDA to move into

PHASE 3

 

   Blisibimod targets elevated levels of B-cell activating factor (BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren's Syndrome, Graves' Disease and others.


  It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab),

now marketed by GlaxoSmithKline and Human Genome Sciences, is the first human monoclonal antibody for the treatment

of lupus.




  Benlysta had a slow take-off grossing $59.2 million in sales in the last three quarters of 2011, but it was approved in numerous

countries by year's end.
Estimated sales for Benlysta in 2012 are said to be about $230 million, with first annual profits likely by 2015.


  The surprisingly slow uptake of Benlysta allows for blisibimod to develop into a promising drug as

it currently has more desirable features than that of Benlysta.


Blisibimod has a dosing regimen of one injection weekly, compared to that of Benlysta which requires a

series of dosing before the maintenance dose begins. Also, Benlysta has limitations on usage pertaining to

specific patient populations and has not been studied in combination with other biologics.

These attributes of blisibimod including a different mechanism of action, will set it apart from

Benlysta, Global Data concludes.

 

 

Cannabis Report
ANTH
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ANTH News: Current Report Filing (8-k) 06/27/2018 04:14:35 PM
ANTH News: Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the... 06/27/2018 08:00:00 AM
ANTH News: Current Report Filing (8-k) 06/18/2018 04:32:02 PM
ANTH News: Current Report Filing (8-k) 05/23/2018 05:27:00 PM
ANTH News: Quarterly Report (10-q) 05/15/2018 04:00:57 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2473  Sticky Note The Pos Scam is heading onto another New Value_Investor 06/30/18 01:00:29 PM
#2476   I'm very glad to have made very nice Value_Investor 07/08/18 11:58:37 PM
#2475   I'm very glad to have bought back my Value_Investor 07/03/18 10:44:29 AM
#2474   Another New low 0.07 was created so far! Value_Investor 07/02/18 10:51:24 AM
#2473   The Pos Scam is heading onto another New Value_Investor 06/30/18 01:00:29 PM
#2472   Wow, ANTH crash to 0.0755 so far! Will Value_Investor 06/29/18 11:51:55 AM
#2471   The Pos Scam (ANTH) just declined to another Value_Investor 06/28/18 11:28:50 AM
#2470   I'm so dang glad that I got out DFRANK1970 06/27/18 07:16:42 PM
#2469   Almost exactly like I predicted a couple of Value_Investor 06/27/18 06:17:06 PM
#2468   * * $ANTH Video Chart 06-27-18 * * ClayTrader 06/27/18 05:05:29 PM
#2467   ANTH delisted from Nasdaq to OTC effective June TenKay 06/27/18 04:37:05 PM
#2466   Look it is being delisted. Good for you Inoviorulez 06/27/18 01:13:00 PM
#2465   POS CEO and garbage company/management. I played this yiannisf 06/27/18 12:23:53 PM
#2464   The Pos Scam is heading onto $0.10xx in Value_Investor 06/22/18 04:27:14 PM
#2463   ANTH President/CEO leaving - "Termination without Cause" ? enforcer1 06/19/18 10:38:02 AM
#2462   Yes. I sold out all my remaining shares Value_Investor 06/12/18 11:51:18 PM
#2461   * * $ANTH Video Chart 06-12-18 * * ClayTrader 06/12/18 05:20:12 PM
#2460   I'm assuming you sold out now? enforcer1 06/12/18 04:06:23 PM
#2459   Kline I said yesterday, this stock is going Stockcaller 06/12/18 10:00:50 AM
#2458   .50 is coming to this stock this week. Stockcaller 06/11/18 07:05:21 PM
#2457   Glad to make huge profit today by selling Value_Investor 06/11/18 06:40:22 PM
#2456   We breached the MA50 today, looking forward to Stockcaller 06/11/18 05:25:27 PM
#2455   $ANTH all indicators pointing to this stock doubling Stockcaller 06/10/18 11:48:05 PM
#2454   From whatsonthorold.com Stockcaller 06/10/18 05:11:26 PM
#2453   Positive earnings is expected this week, could propel Stockcaller 06/10/18 01:35:41 PM
#2452   I bet $0.1 will be the new Final Value_Investor 06/10/18 12:54:09 PM
#2451   From www.tickerreport.com Stockcaller 06/09/18 06:06:41 PM
#2450   ANTH crashed to 0.236 right before the market Value_Investor 06/09/18 03:41:44 PM
#2449   There's a $5.25 price target on $ANTH Stockcaller 06/09/18 02:46:47 AM
#2448   Yes. I've made some very nice gain today Value_Investor 06/08/18 04:59:27 PM
#2447   Chart reversal, expect a run back to .50 Stockcaller 06/08/18 01:45:06 PM
#2446   Looks like you got your selling range for enforcer1 06/08/18 01:04:44 PM
#2445   Eventually she has to go, looks to break Stockcaller 06/08/18 12:19:27 PM
#2444   It seems ANTH might form another higher bottom Value_Investor 06/08/18 12:13:00 PM
#2443   Ether bottoms that you indicated are trending up, Stockcaller 06/08/18 12:46:17 AM
#2442   Well, ANTH was down by -0.0040 or -1.71% Value_Investor 06/07/18 06:32:43 PM
#2441   A breakou seems to be called for by Stockcaller 06/06/18 09:35:58 PM
#2440   IMO, the company Liquidation or Dissolution should give Value_Investor 06/06/18 07:24:10 PM
#2438   Value_Investor, that's a very good question. I'm going DFRANK1970 06/05/18 12:38:30 PM
#2437   I'm out on the spike earlier. On watch enforcer1 06/05/18 12:37:13 PM
#2436   What happened with ANTH? The company phone number Value_Investor 06/05/18 11:39:55 AM
#2435   Who were selling the "endless" shares at $0.213 Value_Investor 06/04/18 05:08:50 PM
#2434   Last Friday in the AH session ANTH did Value_Investor 06/04/18 01:06:12 PM
#2433   soon 0,15 jpowellvlc 06/04/18 10:10:21 AM
#2432   ANTH. 24 lotto play buy n hold PAC 06/04/18 09:08:23 AM
#2431   I have no any confidence with the existing Value_Investor 06/02/18 06:48:10 PM
#2430   Yes, because the majority of my ANTH shares Value_Investor 06/01/18 10:31:02 AM
#2429   1M cheap shares? cool! enforcer1 05/29/18 01:15:21 PM
#2428   It seems $0.213 is the current Bottom though Value_Investor 05/29/18 10:16:18 AM
#2427   Another New low $0.213 so far! What is Value_Investor 05/25/18 11:26:52 AM
#2426   My confidence is still high considering Dr. Christopher enforcer1 05/25/18 09:06:10 AM
PostSubject